Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8681 USD | +1.43% |
|
-3.01% | -2.35% |
Business Summary
Number of employees: 210
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sergio Quezada
FOU | Founder | 49 | 01/20/01 |
Karl Peggs
FOU | Founder | 57 | 01/20/01 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/18/01 |
Robert Coutts
DFI | Director of Finance/CFO | 40 | 01/20/01 |
Edward Samuel
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Shree Patel
COO | Chief Operating Officer | - | - |
James Taylor
PRN | Corporate Officer/Principal | - | 01/22/01 |
Tariq Ahmed
HRO | Human Resources Officer | - | 01/20/01 |
Daniel Hood
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carsten Boess
BRD | Director/Board Member | 57 | 01/20/01 |
Edwin Moses
CHM | Chairman | 69 | - |
Director/Board Member | 69 | 04/22/04 | |
Michael Giordano
BRD | Director/Board Member | 66 | 01/18/01 |
Julie O'Neill
BRD | Director/Board Member | 58 | 03/21/03 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,087,901 | 40,677,022 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Achilles Therapeutics Plc
245 Hammersmith Road
W6 8PW, London
+44 20 8154 4600
http://www.achillestx.com![address Achilles Therapeutics plc(ACHL)](https://cdn.zonebourse.com/static/address/120866204.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.35% | 3.52Cr | |
+38.36% | 5.25TCr | |
+36.73% | 3.93TCr | |
-8.63% | 3.9TCr | |
+25.46% | 2.82TCr | |
-11.17% | 2.66TCr | |
+11.44% | 2.62TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.17TCr |
- Stock Market
- Equities
- ACHL Stock
- Company Achilles Therapeutics plc